Bristol-Myers Squibb stock falls on lung cancer drug study result - MarketWatch

Bristol-Myers Squibb stock falls on lung cancer drug study result  MarketWatch

Bristol-Myers Squibb Co. fell in the extended session Wednesday after the drug maker said its lung cancer drug did not achieve one of its goals in a...



Comments

Popular posts from this blog